Beneficial effects of nicotine
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Nicotine in tobacco brings illness and death to millions of people. Yet nicotine in its pure form has the potential to be a valuable pharmaceutical agent. Nicotine fairly specifically binds to the cholinergic nicotinic gating site on cationic ion channels in receptors throughout the body. This action stimulates the release of a variety of neurotransmitters including especially catecholamines and serotonin. When chronically taken, nicotine may result in: (1) positive reinforcement, (2) negative reinforcement, (3) reduction of body weight, (4) enhancement of performance, and protection against: (5) Parkinson's disease (6) Tourette's disease (7) Alzheimers disease, (8) ulcerative colitis and (9) sleep apnea. The reliability of these effects varies greatly but justifies the search for more therapeutic applications for this interesting compound.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicotinic effects on the firing pattern of midbrain dopamine neurons
GRENHOFF, J., ASTON‐JONES, G., & SVENSSON, T. H. (1986) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1986.tb07988.x · Cited by 399
JANSON, A. M., FUXE, K., SUNDSTRÖM, E., AGNATI, L. F., & GOLDSTEIN, M. (1988) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1988.tb08372.x · Cited by 56
Cited by
Smoking, stress, and negative affect: Correlation, causation, and context across stages of smoking.
Kassel, J. D., Stroud, L. R., & Paronis, C. A. (2003) · Psychological Bulletin · doi:10.1037/0033-2909.129.2.270 · Cited by 1,080
Guidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824
“…and in macaques (Macaca mulatta, Macaca fascicularis, and Macaca nemestrina) with doses generally ranging from 0.001 to 0.056 mg kg −1 (0.3–18 μg kg −1 ) (Buccafusco and Jackson 1991; Buccafusco et al. 1995, 1999; Elrod et al. 1988; Katner et al. 2004; Prendergast et al. 1997; Terry et al. 1993;…”
BackgroundInfluentialCigarette smoking: implications for psychiatric illness
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.546 · Cited by 723
Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal
S. Watkins, G. F. K. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050011277 · Cited by 424
Nicotine effects on adults with attention-deficit/hyperactivity disorder
Levin, E. D., Conners, C. K., Sparrow, E., Hinton, S. C., Erhardt, D., Meck, W. H., Rose, J. E., & March, J. (1996) · Psychopharmacology · doi:10.1007/bf02246281 · Cited by 415
Metadata
- Authors
- JARVIK, M. E.
- Venue
- British Journal of Addiction
- Publisher
- Wiley
- Published
- 1991-05
- Volume
- 86
- Issue
- 5
- Pages
- 571-575
- ISSN
- 0952-0481 (ISSN-L)
- 2056-5178
- OpenAlex
- W2101049421
- Cited by
- 111
- References
- 2
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Beneficial effects of nicotine. https://app.cochat.ai/papers/10.1111/j.1360-0443.1991.tb01810.x
- The paper
- JARVIK, M. E. (1991). Beneficial effects of nicotine. British Journal of Addiction. https://doi.org/10.1111/j.1360-0443.1991.tb01810.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.